Icosavax Inc

ICVX
15,31
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/3/202414:30EDGAR2Form 15-12G - Securities registration termination [Section..
21/2/202422:21EDGAR2Form SC 13D/A - General statement of acquisition of..
21/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
21/2/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/2/202414:43EDGAR2Form POS AM - Post-Effective amendments for registration..
20/2/202414:42EDGAR2Form 8-K - Current report
20/2/202414:32EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
03/2/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202420:25PRNUSKuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to..
24/1/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:04EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/1/202417:10PRNUSKuehn Law Encourages PXD, IMGN, HA and ICVX Investors to..
06/1/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:52EDGAR2Form 144 - Report of proposed sale of securities
03/1/202420:57PRNUSKuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to..
27/12/202314:55EDGAR2Form SC 14D9 - Solicitation, recommendation statements
23/12/202300:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202300:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202300:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:42EDGAR2Form 144 - Report of proposed sale of securities
21/12/202322:28EDGAR2Form 144 - Report of proposed sale of securities
21/12/202302:54EDGAR2Form 144 - Report of proposed sale of securities
21/12/202302:50EDGAR2Form 144 - Report of proposed sale of securities
21/12/202302:50EDGAR2Form 144 - Report of proposed sale of securities
21/12/202302:44EDGAR2Form 144 - Report of proposed sale of securities
20/12/202323:05EDGAR2Form SC14D9C - Written communication relating to third party..
20/12/202322:41EDGAR2Form 144 - Report of proposed sale of securities
16/12/202301:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:18EDGAR2Form SC14D9C - Written communication relating to third party..
13/12/202322:26EDGAR2Form 144 - Report of proposed sale of securities
12/12/202323:00EDGAR2Form SC14D9C - Written communication relating to third party..
12/12/202322:56EDGAR2Form SC14D9C - Written communication relating to third party..
12/12/202322:12EDGAR2Form 8-K - Current report
12/12/202312:25DJNIcosavax Shares Take Flight on Takeover by AstraZeneca
12/12/202309:02DJNAstraZeneca to Buy Icosavax for Up to $1.1 Billion -- Update
12/12/202308:47DJNAstraZeneca to Buy Icosavax for Up to $1.1 Billion
12/12/202308:05GLOBEIcosavax, Inc. Announces Agreement to be Acquired by..
12/12/202308:00GLOBEIcosavax Announces Positive Topline Interim Phase 2 Results..
14/11/202322:05GLOBEIcosavax Reports Third Quarter 2023 Financial Results and..
08/11/202314:00GLOBEIcosavax to Participate in the Jefferies London Healthcare..
31/10/202313:00GLOBEIcosavax to Participate in the Guggenheim Healthcare Talks..
Apertura: Min: Max:
Chiusura: 15,31

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network